The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Pancreatic Adenocarcinoma is the most common pancreatic cancer. This occurs in 90% of all human pancreatic cancers. It is the most devastating disease, with overall 5-year survival rate of only 3–5%. In 2014, it was estimated that in the US, 46,000 new cases will occur with more than 40,000 deaths. This indicates that the current standard of cure is inadequate. Typically they are diagnosed at the...
Pancreatic adenocarcinoma is a highly aggressive pancreatic exocrine malignancy. Only a small proportion of patients have localized disease at presentation that is amenable to surgical resection and that can prolong survival. Work‐up includes high quality cross‐sectional imaging to assess for distant metastasis and to determine locoregional anatomical resectability. For those with biliary obstruction,...
The pitiful response rate of less than 25% to the pancreatic chemodrugs indicates that currently the cancer of pancreas is very difficult to treat. This is because early-stage pancreatic cancer rarely causes any significant symptoms. The condition is often not detected until the cancer is relatively advanced. In addition, the pancreatic cancers are chemoresistant and hence chemotherapy doesn't work...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.